- Report
- September 2024
- 253 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- December 2024
- 159 Pages
Asia Pacific
From €2173EUR$2,500USD£1,891GBP
- Report
- November 2024
- 164 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- November 2024
- 165 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- July 2024
- 136 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- May 2024
- 170 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- February 2024
- 104 Pages
Europe
From €2564EUR$2,950USD£2,231GBP
- Report
- April 2023
- 206 Pages
Global
From €3042EUR$3,500USD£2,647GBP
€6084EUR$7,000USD£5,295GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1065EUR$1,225USD£927GBP
€2129EUR$2,450USD£1,853GBP
- Report
- January 2025
- 284 Pages
Global
From €4345EUR$5,000USD£3,782GBP
- Report
- May 2024
- 200 Pages
Global
From €3607EUR$4,150USD£3,139GBP
From €3042EUR$3,500USD£2,647GBP
- Report
- February 2025
- 85 Pages
India
From €3042EUR$3,500USD£2,647GBP
- Report
- February 2025
- 85 Pages
India
From €3042EUR$3,500USD£2,647GBP
From €3042EUR$3,500USD£2,647GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3042EUR$3,500USD£2,647GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3042EUR$3,500USD£2,647GBP
- Report
- January 2025
- 134 Pages
Europe
From €3476EUR$4,000USD£3,026GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3476EUR$4,000USD£3,026GBP
- Report
- October 2024
- 134 Pages
North America
From €3476EUR$4,000USD£3,026GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more